Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 31 for “"Complement inhibition"”.
-
Multifocal motor neuropathy: a trial of therapeutic complement inhibition, and investigation of serological factors
… potential of these antibodies is reliant upon complement activation, and the resultant formation of the MAC (membrane attack complex). In experimental models of anti-ganglioside mediated neuropathy, inhibition of the complement cascade results in the complete prevention of inflammatory damage, …
-
Improvement of platelet quality in stored platelet concentrates by inhibition of complement activation
… blood collection packs, and aging of platelets. Complement activation occurs in platelet concentrates (PCs) during collection, processing and storage, which may contribute to the platelet storage lesion; however, no direct evidence supports this hypothesis. If complement contributes to the …
-
Diagnostic and therapeutic approaches to hematopoietic stem cell transplant-associated acute kidney injury
… and the clinical impact of early terminal complement inhibition in adult HSCT-TMA patients remains incompletely defined. Objectives. To evaluate kidney function in patients undergoing allogeneic HSCT and assess the impact of early terminal complement inhibition on renal and survival …
-
Material-Induced Platelet and Leukocyte Activation: A Systems Approach
… could not be linked to a sample volume effect. Complement inhibitor FUT-175 reduced PMP formation but had less effect on GPIIb/IIIa expression. Complement inhibition also reduced leukocyte activation, especially under shear conditions. Considerable reduction in leukocyte activation was observed …
-
Characterising complement behaviour and inhibition in normothermic machine perfusion for renal transplantation
… a platform for ex vivo therapeutic delivery. Complement is a major mediator of transplant injury, yet its behaviour during renal NMP and its suitability as a graft-directed therapeutic target remain incompletely understood.<br><br>This thesis characterises complement activation during renal …
-
The role of complement system activation in placental ischemia-induced hypertension
… as evidenced by elevations in innate immune complement activation products, including C3a. Decreased circulating free vascular endothelial growth factor (VEGF) is a known contributor to preeclampsia and previous studies have demonstrated a link between VEGF and complement. We therefore …
-
Borrelia burgdorferi ErpB and ErpQ inhibit C1 complex of the classical pathway of complement through a novel mechanism
The complement system is an organized proteolytic cascade of dozens of proteins that functions in the recognition, opsonization, and lysis of pathogenic and altered-host cells. Bloodborne pathogens like the etiologic agent of Lyme disease, Borrelia burgdorferi, encounter complement during their …
-
DEVELOPMENT OF SMALL-MODELCULE INHIGITORS OF THE INTIATING PROTEASES, C1r AND C1s, OF THE CLASSICAL COMPLEMENT PATHWAY
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate immune system and acts to prime the adaptive immune response. During normal homeostatic events, complement is tightly regulated for its roles in immune complex clearance, lysis of target cells, …
-
Development of small-molecule inhibitors of the initiating proteases, C1r and C1s, of the classical complement pathway
Complement is a proteolytic cascade that upon activation plays a key effector role in the innate immune system and acts to prime the adaptive immune response. During normal homeostatic events, complement is tightly regulated for its roles in immune complex clearance, lysis of target cells, …
-
Development and biophysical characterization of a hyaluronic acid – vitamin E conjugate as a subcutaneous delivery platform
… Coversin from the HAtoco nanogel demonstrated complement inhibition for at least 73 hours in vitro. Overall, HAtoco has demonstrated the ability to bind protein therapeutics in a reversible manner capable of prolonging their release in a therapeutically efficacious state.
-
Molecular basis of pneumococcal adherence and complement evasion : structural and biochemical studies of pneumococcal virulence factor, CbpA
Molecular Basis of Pneumococcal Adherence and Complement Evasion: Structural and Biochemical Studies of Pneumococcal Virulence Factor CbpA ByDavid Otieno AchilaStreptococcus pneumoniae is a human adapted pathogen of global importance as a leading cause of a wide spectrum of infections, such as …
-
Characterization of Staphylococcal Superantigen-Like Protein 10 (SSL10)
… of the human immune system, including IgG, the complement system and the coagulation system, and thus is potentially important in S. aureus immune evasion. SSL10 binds IgG through its β-grasp domain via an interface formed by β10, β11 and the loop in between the two strands, with residues F166, …
-
Cardioprotective treatment strategies
In myocardial ischemia-reperfusion (I/R) injury, complement activation, tissue plasminogen activator (t-PA) and extracellular adenosine triphosphate (ATP) release contribute to myocardial injury. ATP is degraded into adenosine by the enzyme apyrase, and adenosine possesses cardioprotective …
-
Strategies for generating therapeutic antibodies
… antibody candidate with a novel mechanism for inhibition of a therapeutically relevant biochemical pathway: the classical complement pathway. In order to inhibit classical complement, an antibody was developed that modulates the signaling subcomponent of the pathway initiating C1 complex, C1s. …
-
Segregating neuronal and glial membrane injury in an anti-GM1 antibody-mediated neuropathy
… antibody. We investigated the effects of complement-mediated injury at the distal motor neuromuscular junction (NMJ) and distal node of Ranvier (NoR). Results demonstrated that injury to the axonal membrane in GalNAc-T-/--Tg(neuronal) mice resulted in a significant reduction of axonal …
-
Enhancing the Delivery of Oncolytic Vaccinia Virus to the Tumors of Hosts with Pre-Existing Immunity
… through the function of antibody and complement, poses a significant hurdle to the IV delivery of infectious virus to dispersed tumor beds. This is of particular importance for therapeutic vaccinia viruses as a majority of today’s cancer patients were vaccinated during the smallpox …
-
Μελέτη της ενεργοποίησης του συμπληρώματος σε ενήλικες ασθενείς με δρεπανοκυτταρική νόσο
… small vessels leading to hemolysis, the role of complement activation has been increasingly investigated. Despite these advances there is still no specific treatment for the disease’s complications. It was hypothesized that complement activation and thromboinflammation are evident in SCD, …
-
Complement evasion strategies of human pathogens - the evolutionary arms race
Although the complement system, a pivotal component of innate immunty, is centrally involved in host defense against pathogens, its overactivation or deregulation may excessively amplify inflammation and contribute to immunopathology. Periodontitis, an oral infection-driven chronic inflammatory …
-
Self-assembling functionalised peptides into decellularised materials for application in small diameter vascular grafts
… loop thrombosis model, a haemolysis assay and a complement inhibition assay. The results showed that large poly-cationic peptides were non-bio or haemo compatible, large neutral peptides enhanced thrombosis formation and that poly-anionic peptides with hydrophobic cores inhibited the complement …
Page 1 of 2